BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14529377)

  • 1. On the generation of novel anticancer drugs by recombinant DNA technology: the use of combinatorial biosynthesis to produce novel drugs.
    Méndez C; Salas JA
    Comb Chem High Throughput Screen; 2003 Sep; 6(6):513-26. PubMed ID: 14529377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of novel chemotherapeutic drugs by Streptomycetes.
    Rassi H; Ghasemi SF
    Lik Sprava; 2008; (7-8):40-7. PubMed ID: 19663015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the scope of aromatic polyketides by combinatorial biosynthesis.
    Kantola J; Kunnari T; Mäntsälä P; Ylihonkoa K
    Comb Chem High Throughput Screen; 2003 Sep; 6(6):501-12. PubMed ID: 14529376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis.
    Olano C; Méndez C; Salas JA
    Nat Prod Rep; 2009 May; 26(5):628-60. PubMed ID: 19387499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights on the biosynthesis of antitumour compounds by actinomycetes.
    Olano C; Méndez C; Salas JA
    Microb Biotechnol; 2011 Mar; 4(2):144-64. PubMed ID: 21342461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthetic modularity rules in the bisintercalator family of antitumor compounds.
    Fernández J; Marín L; Alvarez-Alonso R; Redondo S; Carvajal J; Villamizar G; Villar CJ; Lombó F
    Mar Drugs; 2014 May; 12(5):2668-99. PubMed ID: 24821625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic manipulation of antitumor-agent biosynthesis to produce novel drugs.
    Salas JA; Méndez C
    Trends Biotechnol; 1998 Nov; 16(11):475-82. PubMed ID: 9830156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and engineering of the biosynthesis gene cluster for antitumor macrolides PM100117 and PM100118 from a marine actinobacteria: generation of a novel improved derivative.
    Salcedo RG; Olano C; Gómez C; Fernández R; Braña AF; Méndez C; de la Calle F; Salas JA
    Microb Cell Fact; 2016 Feb; 15():44. PubMed ID: 26905289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic engineering of natural product biosynthesis in actinobacteria.
    Bilyk O; Luzhetskyy A
    Curr Opin Biotechnol; 2016 Dec; 42():98-107. PubMed ID: 27058643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure alteration of polyketides by recombinant DNA technology in producer organisms--prospects for the generation of novel pharmaceutical drugs.
    Méndez C; Weitnauer G; Bechthold A; Salas JA
    Curr Pharm Biotechnol; 2000 Dec; 1(4):355-95. PubMed ID: 11467332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial and synthetic biosynthesis in actinomycetes.
    Luzhetska M; Härle J; Bechthold A
    Fortschr Chem Org Naturst; 2010; 93():211-37. PubMed ID: 20556678
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosynthesis of enediyne antitumor antibiotics.
    Van Lanen SG; Shen B
    Curr Top Med Chem; 2008; 8(6):448-59. PubMed ID: 18397168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic biology of secondary metabolite biosynthesis in actinomycetes: Engineering precursor supply as a way to optimize antibiotic production.
    Wohlleben W; Mast Y; Muth G; Röttgen M; Stegmann E; Weber T
    FEBS Lett; 2012 Jul; 586(15):2171-6. PubMed ID: 22710162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis of sibiromycin, a potent antitumor antibiotic.
    Li W; Khullar A; Chou S; Sacramo A; Gerratana B
    Appl Environ Microbiol; 2009 May; 75(9):2869-78. PubMed ID: 19270142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.
    Lombó F; Menéndez N; Salas JA; Méndez C
    Appl Microbiol Biotechnol; 2006 Nov; 73(1):1-14. PubMed ID: 17013601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial chromosomes to explore and to exploit biosynthetic capabilities of actinomycetes.
    Alduina R; Gallo G
    J Biomed Biotechnol; 2012; 2012():462049. PubMed ID: 22919271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and advances in genetic manipulation of filamentous actinomycetes - the remarkable producers of specialized metabolites.
    Musiol-Kroll EM; Tocchetti A; Sosio M; Stegmann E
    Nat Prod Rep; 2019 Sep; 36(9):1351-1369. PubMed ID: 31517370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolocarbazole antitumour compounds by combinatorial biosynthesis.
    Salas JA; Méndez C
    Curr Opin Chem Biol; 2009 Apr; 13(2):152-60. PubMed ID: 19251468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enzymology of combinatorial biosynthesis.
    Reeves CD
    Crit Rev Biotechnol; 2003; 23(2):95-147. PubMed ID: 12889743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial biosynthesis, metabolic engineering and mutasynthesis for the generation of new aminocoumarin antibiotics.
    Heide L; Gust B; Anderle C; Li SM
    Curr Top Med Chem; 2008; 8(8):667-79. PubMed ID: 18473891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.